SOPHiA GENETICS SA
Organization details
- Legal name
- SOPHiA GENETICS SA
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Information Technology
- SIC code
- 7374 — Services-Computer Processing & Data Preparation
- Jurisdiction of incorporation
- Switzerland
- Headquarters city
- Rolle
- Headquarters country
- Switzerland
- Fiscal year end
- December
- Ticker symbol
- SOPH
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001840706
Board of directors
-
Didier Hirsch · DirectorSince 2026
-
Jean-Michel Cossery · DirectorSince 2026
-
Jurgi Camblong · Director · Executive ChairmanSince 2026
-
Kathy L. Hibbs · DirectorSince 2026
-
Ross Muken · Director · Chief Executive OfficerSince 2026
-
Tomer Berkovitz · DirectorSince 2026
-
Troy Cox · DirectorSince 2026
-
Vincent Ossipow · DirectorSince 2026
Chief executives
Board connections
3 of this board's directors also sit on 5 other boards.
- via Kathy L. Hibbs and Troy Cox
- via Didier Hirsch
- via Didier Hirsch
- via Troy Cox
- via Troy Cox
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $377,388
- 3 purchases by 2 insiders
- Sold, last 12 months
- $5,053,967
- 147 sales by 10 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 6, 2026 | CARDOZA GEORGE Officer (Chief Financial Officer) | Open-market purchase | +20,000 | $7.06 | $141,200 |
| Nov 6, 2026 | Ross Muken Director, Officer (Chief Executive Officer) | Open-market purchase | +20,000 | $6.86 | $137,188 |
| Oct 5, 2026 | CARDOZA GEORGE Officer (Chief Financial Officer) | Open-market sale | −1,592 | $8.10 | $12,897 |
| Oct 5, 2026 | Jurgi Camblong Director, Officer (Executive Chairman) | Open-market sale | −40,172 | $8.13 | $326,526 |
| Oct 5, 2026 | Menu Philippe Officer (Chief Medical Officer) | Open-market sale | −7,394 | $8.13 | $60,100 |
| Oct 5, 2026 | Ross Muken Director, Officer (Chief Executive Officer) | Open-market sale | −9,838 | $8.13 | $79,971 |
| Oct 5, 2026 | Puylaert Kevin Officer (Chief Sales Officer) | Open-market sale | −185 | $8.06 | $1,491 |
| Oct 5, 2026 | Xu Zhenyu Officer (Chief Scientific Officer) | Open-market sale | −7,394 | $8.12 | $60,075 |
| Oct 5, 2026 | Verma Abhimanyu Officer (Chief Technology Officer) | Open-market sale | −5,284 | $8.12 | $42,929 |
| Oct 5, 2026 | Valente Manuela Officer (Chief People Officer) | Open-market sale | −4,240 | $8.13 | $34,487 |
| Oct 5, 2026 | Van Well Daan Officer (Chief Legal Officer) | Open-market sale | −6,168 | $8.12 | $50,100 |
| Oct 5, 2026 | Puylaert Kevin Officer (Chief Sales Officer) | Open-market sale | −31 | $7.92 | $246 |
| Sep 21, 2026 | CARDOZA GEORGE Officer (Chief Financial Officer) | Open-market sale | −774 | $8.33 | $6,447 |
| Sep 21, 2026 | Ross Muken Director, Officer (Chief Executive Officer) | Open-market sale | −422 | $8.33 | $3,515 |
| Sep 14, 2026 | Menu Philippe Officer (Chief Medical Officer) | Open-market sale | −5,000 | $7.88 | $39,400 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about SOPHiA GENETICS SA
Who is the CEO of SOPHiA GENETICS SA?
Jurgi Camblong has been SOPHiA GENETICS SA's Chief Executive Officer since March 2026.
How many directors are on SOPHiA GENETICS SA's board?
SOPHiA GENETICS SA's board has 8 directors: Didier Hirsch, Jean-Michel Cossery, Jurgi Camblong, Kathy L. Hibbs, Ross Muken, Tomer Berkovitz, Troy Cox and Vincent Ossipow.
Are SOPHiA GENETICS SA insiders buying or selling shares?
Over the last 12 months, SOPHiA GENETICS SA insiders bought $377,388 of shares in 3 purchases and sold $5.1 million of shares in 147 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="sophia-genetics-sa"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.